Anja Moldenhauer

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Germany
    BMC Immunol 9:56. 2008
  2. ncbi Differences in the transmigration of different dendritic cells
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Exp Hematol 34:745-52. 2006
  3. ncbi Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins
    Anja Moldenhauer
    Institute for Transfusion Medicine and Immunehaematology, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    J Leukoc Biol 76:623-33. 2004
  4. ncbi Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia
    Kerstin Schmidt
    Institute for Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany
    J Leukoc Biol 85:563-73. 2009
  5. ncbi Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Immunol 41:1774-86. 2011
  6. ncbi Transcriptional profiling of the hematopoietic support of interleukin-stimulated human umbilical vein endothelial cells (HUVECs)
    Gürkan Bal
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Cell Transplant 21:251-67. 2012
  7. ncbi Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite, Universitätsmedizen Berlin, Berlin, Germany
    Stem Cells 22:144-57. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Germany
    BMC Immunol 9:56. 2008
    ..HPC were assessed by flow cytometry, colony and cobblestone assays and long-term cultures (LTC) after culturing in the supernatant of EC stimulated by IL-1beta, IL-3 or IL-6...
  2. ncbi Differences in the transmigration of different dendritic cells
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Exp Hematol 34:745-52. 2006
    ..Their ability to migrate to the adjacent lymphatic system is relevant since their efficacy does also rely on their potential to interact with lymphocytes...
  3. ncbi Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins
    Anja Moldenhauer
    Institute for Transfusion Medicine and Immunehaematology, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    J Leukoc Biol 76:623-33. 2004
    ..This model system suggests that the Hdi supports the in vitro differentiation of DC from leukemic blasts with AML1-containing fusion proteins...
  4. ncbi Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia
    Kerstin Schmidt
    Institute for Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany
    J Leukoc Biol 85:563-73. 2009
    ..Therefore, the use of HdI in the differentiation of leukemic DC from patients with TEL/AML1-positive ALL is recommended...
  5. ncbi Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Immunol 41:1774-86. 2011
    ..Our findings confirm that the combination of microarrays and gene annotation helps to identify new hematopoietic growth factors...
  6. ncbi Transcriptional profiling of the hematopoietic support of interleukin-stimulated human umbilical vein endothelial cells (HUVECs)
    Gürkan Bal
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Cell Transplant 21:251-67. 2012
    ..Our results suggest that microarray in combination with functional annotations is a convenient method to identify novel factors with great impact on HPC proliferation and differentiation...
  7. ncbi Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells
    Anja Moldenhauer
    Institute for Transfusion Medicine, Charite, Universitätsmedizen Berlin, Berlin, Germany
    Stem Cells 22:144-57. 2004
    ..We conclude that, via the action of TNF-alpha, inflamed human endothelium can induce CD34+ and leukemic cells to differentiate into dendritic cells...